Related references
Note: Only part of the references are listed.Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N. D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer
Jamie L. Van Etten et al.
CANCER RESEARCH (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Kristine M. Wadosky et al.
ONCOTARGET (2016)
The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP
Mark P. Hamilton et al.
NEOPLASIA (2016)
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen
Olivia Larne et al.
EUROPEAN UROLOGY (2015)
miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy
Junfei Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
miR-346 and miR-138 competitively regulate hTERT in GRSF1-and AGO2-dependent manners, respectively
Ge Song et al.
SCIENTIFIC REPORTS (2015)
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer
Esra Guzel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
Kathryn E. Ware et al.
ENDOCRINE-RELATED CANCER (2014)
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
Z. Hagman et al.
BRITISH JOURNAL OF CANCER (2013)
MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor
Fajun Qu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer
Michael D. Nyquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival
Taro Murata et al.
CLINICAL CANCER RESEARCH (2012)
MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
Nagalakshmi Nadiminty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Rac1 Activation Driven by 14-3-3ζ Dimerization Promotes Prostate Cancer Cell-Matrix Interactions, Motility and Transendothelial Migration
Anna Goc et al.
PLOS ONE (2012)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
miR 488☆ inhibits androgen receptor expression in prostate carcinoma cells
Kavleen Sikand et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A Snapshot of the Expression Signature of Androgen Receptor Splicing Variants and Their Distinctive Transcriptional Activities
Rong Hu et al.
PROSTATE (2011)
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Daehwan Kim et al.
GENOME BIOLOGY (2011)
MicroRNAs and prostate cancer
Yingxin Pang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53
Zhe-Wei Zhang et al.
ASIAN JOURNAL OF ANDROLOGY (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
MicroRNA function in cancer: oncogene or a tumor suppressor?
Sylvia K. Shenouda et al.
CANCER AND METASTASIS REVIEWS (2009)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
D. Alwyn Dart et al.
ENDOCRINE-RELATED CANCER (2009)
miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer
Michael R. Epis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
Stefan Ambs et al.
CANCER RESEARCH (2008)
Widespread deregulation of microRNA expression in human prostate cancer
M. Ozen et al.
ONCOGENE (2008)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Madhu S. Kumar et al.
NATURE GENETICS (2007)
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
S. C. Gamble et al.
ONCOGENE (2007)
Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor - Transactivation and prostate cancer cell growth
Zhiming Yang et al.
MOLECULAR ENDOCRINOLOGY (2007)
Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer
Kati K. Waltering et al.
PROSTATE (2006)
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
G. Wang et al.
ONCOGENE (2006)
Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells
Minna Takkunen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation
Irene E. Zohn et al.
CELL (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis
BL Zhang et al.
CANCER RESEARCH (2005)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Androgens target prohibitin to regulate proliferation of prostate cancer cells
SC Gamble et al.
ONCOGENE (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
IK Mellinghoff et al.
CANCER CELL (2004)
Improved statistical methods for hit selection in high-throughput screening
C Brideau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Share Paper
